Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,500.00
0.00 (0.00%)
Aug 14, 2026, 4:16 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 78.37 million as of August 14, 2026. Its market cap has decreased by -35.34% in one year.
Market Cap
78.37M
Enterprise Value
73.07M
Revenue
12.54M
Ranking
n/a
PE Ratio
10.67
Stock Price
1,500.00
ChartMarket Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 78.37M, an increase of 695.87%. That is a compound annual growth rate of 13.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 78.37M | -21.26% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 115.89M |
| Faron Pharmaceuticals Oy | 91.98M |
| 4basebio | 85.46M |
| Ondine Biomedical | 71.44M |
| Poolbeg Pharma | 66.04M |
| hVIVO | 46.03M |
| Hemogenyx Pharmaceuticals | 43.18M |
| Sareum Holdings | 35.33M |